NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Open in Screener

HCWB

HCW Biologics Inc

May 08 • 04:00PM ET

7.15

Dollar change +0.14
Percentage change 2.00	%

Healthcare • Biotechnology • USA • NASD

Peers: LGND AUPH BYSI IVA FATE ARDX GERN CRBP TVRD GLYC

| Held by: VXF IWC

Index	-	P/E	-	EPS (ttm)	-31.50	Insider Own	40.56%	Shs Outstand	1.11M	Perf Week	-7.55%
Market Cap	8.03M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.67M	Perf Month	-16.47%
Income	-30.02M	PEG	-	EPS next Q	-	Inst Own	11.32%	Short Float	1.33%	Perf Quarter	-58.39%
Sales	2.57M	P/S	3.12	EPS this Y	-	Inst Trans	-	Short Ratio	0.88	Perf Half Y	-58.43%
Book/sh	-6.08	P/B	-	EPS next Y	-	ROA	-102.21%	Short Interest	0.01M	Perf Year	-86.04%
Cash/sh	4.16	P/C	1.72	EPS next 5Y	-	ROE	-897.37%	52W Range	6.36 - 100.80	Perf YTD	-59.93%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-29.55%	ROI	-4940.62%	52W High	-92.91%	Beta	0.85
Dividend TTM	-	Quick Ratio	0.19	Sales past 5Y	-33.48%	Gross Margin	-8.77%	52W Low	12.42%	ATR (14)	0.93
Dividend Ex-Date	-	Current Ratio	0.19	EPS Y/Y TTM	-13.26%	Oper. Margin	-650.16%	RSI (14)	36.95	Volatility	11.34% 11.32%
Employees	36	Debt/Eq	-	Sales Y/Y TTM	-9.68%	Profit Margin	-1169.70%	Recom	1.00	Target Price	120.00
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	73.13%	Payout	-	Rel Volume	1.46	Prev Close	7.01
Sales Surprise	-98.87%	EPS Surprise	-188.89%	Sales Q/Q	-70.18%	Earnings	Mar 28 BMO	Avg Volume	10.05K	Price	7.15
SMA20	-7.76%	SMA50	-32.42%	SMA200	-58.23%	Trades		Volume	14,545	Change	2.00%

Apr-01-25 04:35PM	HCW Biologics Announces 1-for-40 Reverse Stock Split (GlobeNewswire)
Mar-28-25 03:30PM	HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results (GlobeNewswire)
Mar-06-25 06:55AM	HCW Biologics Granted Extension by the Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements (GlobeNewswire)
Feb-03-25 07:15AM	HCW Biologics Granted FDA Clearance to Evaluate One of the Company's Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial (GlobeNewswire) +128.58%
Jan-15-25 07:00AM	HCW Biologics' Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025 (GlobeNewswire)
08:10AM	Loading…
Dec-23-24 08:10AM	HCW Biologics Inc. Received NASDAQ Staff Determination Letter (GlobeNewswire) -11.18%
Nov-20-24 01:55AM	HCW Biologics prices $6.9M registered direct offering at $1.03 per share (TipRanks) -13.89%
Nov-18-24 09:27PM	HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules (GlobeNewswire) +320.91% -11.29%
10:15AM	Why Is Penny Stock HCW Biologics Surging On Monday? (Benzinga)
07:00AM	HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate (GlobeNewswire)
Nov-14-24 04:40PM	HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights (GlobeNewswire)
Aug-23-24 04:30PM	HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction (GlobeNewswire) +11.64% -11.21%
Aug-14-24 04:35PM	HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights (GlobeNewswire) -13.62%
May-15-24 09:53PM	HCWB Stock Earnings: HCW Biologics Reported Results for Q1 2024 (InvestorPlace) -5.17%
04:39PM	HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights (GlobeNewswire)
10:53PM	Loading…
Apr-01-24 10:53PM	HCWB Stock Earnings: HCW Biologics Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace) -5.71%
04:10PM	HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights (GlobeNewswire)
Nov-14-23 07:00AM	HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights (GlobeNewswire) -17.73%
Nov-08-23 07:30AM	Investigator Sponsor of HCW Biologics' Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting (GlobeNewswire)
Nov-01-23 07:30AM	Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting (GlobeNewswire) -5.36%
Sep-16-23 11:00AM	Insider Buying: CFO Rebecca Byam Acquires 5,000 Shares of HCW Biologics Inc (GuruFocus.com)
Sep-14-23 01:27PM	Insider Buying: CFO Rebecca Byam Acquires 10,000 Shares of HCW Biologics Inc (GuruFocus.com) +5.45%
Sep-09-23 01:00PM	Insider Buying: CFO Rebecca Byam Acquires 10,000 Shares of HCW Biologics Inc (GuruFocus.com)
Sep-06-23 07:30AM	HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 13, 2023 (GlobeNewswire)
Aug-11-23 07:01AM	Daily Vickers Top Insider Picks for 08/11/2023 (Argus Research)
07:00AM	HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights (GlobeNewswire)
Aug-10-23 06:24AM	Daily Vickers Top Insider Picks for 08/10/2023 (Argus Research)
Aug-09-23 06:26AM	Daily Vickers Top Insider Picks for 08/09/2023 (Argus Research)
Aug-08-23 06:28AM	Daily Vickers Top Insider Picks for 08/08/2023 (Argus Research)
Aug-07-23 06:35AM	Daily Vickers Top Insider Picks for 08/07/2023 (Argus Research)
07:14AM	Loading…
Aug-04-23 07:14AM	Daily Vickers Top Insider Picks for 08/04/2023 (Argus Research) -8.26%
Aug-03-23 07:15AM	Daily Vickers Top Insider Picks for 08/03/2023 (Argus Research)
Aug-02-23 07:52AM	Daily Vickers Top Insider Picks for 08/02/2023 (Argus Research)
Aug-01-23 06:51AM	Daily Vickers Top Insider Picks for 08/01/2023 (Argus Research)
Jul-31-23 06:44AM	Daily Vickers Top Insider Picks for 07/31/2023 (Argus Research)
Jul-28-23 07:58AM	Daily Vickers Top Insider Picks for 07/28/2023 (Argus Research)
Jul-27-23 07:10AM	Daily Vickers Top Insider Picks for 07/27/2023 (Argus Research)
Jul-26-23 01:12PM	Daily Vickers Top Insider Picks for 07/26/2023 (Argus Research)
Jul-25-23 07:16AM	Daily Vickers Top Insider Picks for 07/25/2023 (Argus Research)
Jul-24-23 07:12AM	Daily Vickers Top Insider Picks for 07/24/2023 (Argus Research)
Jul-21-23 07:23AM	Daily Vickers Top Insider Picks for 07/21/2023 (Argus Research)
Jul-20-23 06:55AM	Daily Vickers Top Insider Picks for 07/20/2023 (Argus Research)
Jul-19-23 07:10AM	Daily Vickers Top Insider Picks for 07/19/2023 (Argus Research)
Jul-18-23 06:53AM	Daily Vickers Top Insider Picks for 07/18/2023 (Argus Research)
Jul-17-23 07:10AM	Daily Vickers Top Insider Picks for 07/17/2023 (Argus Research) +5.42%
Jul-14-23 06:50AM	Daily Vickers Top Insider Picks for 07/14/2023 (Argus Research) -8.23%
Jul-13-23 07:02AM	Daily Vickers Top Insider Picks for 07/13/2023 (Argus Research) +6.45%
Jul-12-23 07:22AM	Daily Vickers Top Insider Picks for 07/12/2023 (Argus Research)
Jul-11-23 06:08AM	Daily Vickers Top Insider Picks for 07/11/2023 (Argus Research)
Jul-10-23 06:56AM	Daily Vickers Top Insider Picks for 07/10/2023 (Argus Research)
Jul-07-23 06:28AM	The past year for HCW Biologics (NASDAQ:HCWB) investors has not been profitable (Simply Wall St.)
Jul-05-23 06:46AM	Daily Vickers Top Insider Picks for 07/05/2023 (Argus Research)
Jul-03-23 06:50AM	Daily Vickers Top Insider Picks for 07/03/2023 (Argus Research)
Jun-30-23 06:52AM	Daily Vickers Top Insider Picks for 06/30/2023 (Argus Research)
Jun-29-23 06:49AM	Daily Vickers Top Insider Picks for 06/29/2023 (Argus Research)
Jun-28-23 06:58AM	Daily Vickers Top Insider Picks for 06/28/2023 (Argus Research)
Jun-27-23 06:46AM	Daily Vickers Top Insider Picks for 06/27/2023 (Argus Research)
Jun-26-23 06:41AM	Daily Vickers Top Insider Picks for 06/26/2023 (Argus Research) -5.22%
Jun-23-23 09:24AM	Daily Vickers Top Insider Picks for 06/23/2023 (Argus Research) +12.75%
Jun-22-23 07:05AM	Daily Vickers Top Insider Picks for 06/22/2023 (Argus Research)
Jun-21-23 07:05AM	Daily Vickers Top Insider Picks for 06/21/2023 (Argus Research)
Jun-20-23 06:35AM	Daily Vickers Top Insider Picks for 06/20/2023 (Argus Research)
Jun-15-23 06:38AM	Daily Vickers Top Insider Picks for 06/15/2023 (Argus Research)
Jun-14-23 07:30AM	HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorders (GlobeNewswire)
06:39AM	Daily Vickers Top Insider Picks for 06/14/2023 (Argus Research)
Jun-13-23 06:37AM	Daily Vickers Top Insider Picks for 06/13/2023 (Argus Research)
Jun-12-23 06:47AM	Daily Vickers Top Insider Picks for 06/12/2023 (Argus Research)
Jun-09-23 06:34AM	Daily Vickers Top Insider Picks for 06/09/2023 (Argus Research) -6.05%
May-10-23 06:13AM	HCW Biologics First Quarter 2023 Earnings: US$0.14 loss per share (vs US$0.057 loss in 1Q 2022) (Simply Wall St.)
May-09-23 07:15AM	HCW Biologics Reports First Quarter 2023 Financial Results And Recent Business Highlights (GlobeNewswire)
Apr-27-23 07:40AM	HCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan (GlobeNewswire)
Apr-13-23 07:15AM	HCW Biologics Poster Presentation at AACR Annual Meeting 2023 (GlobeNewswire)
Apr-03-23 08:13AM	A Novel Immunotherapeutic Approach to Treating Aging-Associated Diseases (GlobeNewswire)
Mar-28-23 04:25PM	HCW Biologics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights (GlobeNewswire) +9.77%
Feb-13-23 05:21AM	Bullish HCW Biologics Inc. (NASDAQ:HCWB) insiders filled their treasuries with US$687k worth of stock over last year (Simply Wall St.)
Jan-03-23 07:50AM	HCW Biologics (NASDAQ:HCWB) shareholders have endured a 18% loss from investing in the stock a year ago (Simply Wall St.)
Dec-08-22 07:55AM	HCW Biologics Enters CRADA with National Cancer Institute (GlobeNewswire)
Dec-07-22 07:30AM	HCW Biologics is Granted Second Fundamental Patent: U.S. Patent for Multi-Chain Chimeric Polypeptide Created with TOBI Platform (GlobeNewswire)
Nov-08-22 07:00AM	Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation From the Phase 1 Clinical Trial to Evaluate HCW9218 in Solid Tumors At the SITC 37th Annual Meeting (GlobeNewswire)
Nov-07-22 04:45PM	HCW Biologics Reports Third Quarter 2022 Financial Results And Recent Business Highlights (GlobeNewswire)
Aug-28-22 08:06AM	Trade Alert: The Chief Financial Officer Of HCW Biologics Inc. (NASDAQ:HCWB), Rebecca Byam, Has Just Spent US$230k Buying 58% More Shares (Simply Wall St.)
Aug-12-22 07:00AM	HCW Biologics Reports Second Quarter 2022 Financial Results And Recent Business Highlights (GlobeNewswire) +7.98%
Aug-03-22 07:15AM	U.S. Patent Issued to HCW Biologics for Foundational Platform Technology (GlobeNewswire)
Jul-27-22 07:56AM	HCW Biologics (NASDAQ:HCWB) shareholders have endured a 57% loss from investing in the stock a year ago (Simply Wall St.)
Jun-27-22 06:27AM	Companies Like HCW Biologics (NASDAQ:HCWB) Are In A Position To Invest In Growth (Simply Wall St.)
May-23-22 07:30AM	HCW Biologics to Participate in H.C. Wainwright Annual Global Life Sciences Conference May 23 25, 2022 (GlobeNewswire)
May-13-22 07:15AM	HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highlights (GlobeNewswire)
May-05-22 07:30AM	HCW Biologics to Showcase Two Novel Groups of Fusion Molecules Created with Proprietary and Versatile TOBI Platform At the 105th Annual Meeting of the American Association of Immunologists (GlobeNewswire)
Apr-19-22 07:33AM	HCW Biologics CEO Hing C. Wong, Ph.D., to be Featured Speaker at the Third Annual International Conference on Cell and Experimental Biology 2022 (GlobeNewswire)
Apr-02-22 01:10PM	Favorable turn of events for HCW Biologics Inc. (NASDAQ:HCWB) insiders who've lost US$4.2m to date on a US$6.9m purchase (Simply Wall St.)
Mar-28-22 07:00AM	HCW Biologics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights for 2021 (GlobeNewswire) -6.59%
Mar-24-22 08:00AM	HCW Biologics to Present at 2022 Virtual Growth Conference Sponsored by the Maxim Group and M-Vest (GlobeNewswire)
Jan-24-22 09:22AM	Masonic Cancer Center To Evaluate HCW Biologics' Bifunctional Fusion Protein In Advanced Cancers (Benzinga) +5.45%
07:00AM	Masonic Cancer Center at the University of Minnesota Receives FDA Clearance to Proceed with Phase 1 Clinical Trial in Solid Tumors for HCW9218, HCW Biologics Novel Bifunctional Fusion Protein (GlobeNewswire)
Jan-20-22 09:24AM	HCW Biologics Lead Candidate Shows Preclinical Anti-Tumor Activity, Reduced Side Effects of Chemo (Benzinga) +12.08%
08:00AM	HCW Biologics Inc. Announces its Lead Product Candidate Shown to Augment Anti-Tumor Activity and Reduce Side Effects of Chemotherapy Regimens (GlobeNewswire)
Jan-19-22 08:00AM	HCW Biologics Founder and CEO Dr. Hing C. Wong Participating in Cambridge Healthtech Institutes Annual PepTalk Conference 2022 (GlobeNewswire)
Jan-18-22 06:27AM	Companies Like HCW Biologics (NASDAQ:HCWB) Are In A Position To Invest In Growth (Simply Wall St.)
Jan-06-22 07:33AM	HCW Biologics to Participate in H.C. Wainwright BioConnect Conference January 10 13, 2022 (GlobeNewswire)
Dec-13-21 07:31AM	HCW Biologics Founder and CEO Dr. Hing C. Wong Named Weaver H. Gaines Entrepreneur of the Year (GlobeNewswire)

HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. The firm considers age-related low-grade chronic inflammation as a contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. The company was founded by Hing C. Wong on April 2, 2018 and is headquartered in Miramar, FL.

Open in Screener

LNSR

LENSAR Inc

May 08 • 04:00PM ET

13.81

Dollar change -0.02
Percentage change -0.14	%

Healthcare • Medical Devices • USA • NASD

Peers: STAA ICUI IART CERS ATEC HAE MLAB CUTR LMAT

| Held by: VTI VXF DFAT DFAS IWC DFAC DFUS AVSC DCOR

Index	-	P/E	-	EPS (ttm)	-2.72	Insider Own	22.59%	Shs Outstand	11.79M	Perf Week	-1.29%
Market Cap	162.85M	Forward P/E	-	EPS next Y	-0.11	Insider Trans	0.00%	Shs Float	9.13M	Perf Month	2.75%
Income	-31.40M	PEG	-	EPS next Q	-0.07	Inst Own	39.84%	Short Float	2.29%	Perf Quarter	27.63%
Sales	57.06M	P/S	2.85	EPS this Y	85.68%	Inst Trans	-4.96%	Short Ratio	1.18	Perf Half Y	135.67%
Book/sh	-1.88	P/B	-	EPS next Y	70.66%	ROA	-46.22%	Short Interest	0.21M	Perf Year	330.22%
Cash/sh	2.14	P/C	6.45	EPS next 5Y	-	ROE	-95.42%	52W Range	3.21 - 17.31	Perf YTD	54.47%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-14.63%	ROI	-	52W High	-20.22%	Beta	0.56
Dividend TTM	-	Quick Ratio	2.04	Sales past 5Y	13.15%	Gross Margin	46.23%	52W Low	330.22%	ATR (14)	0.32
Dividend Ex-Date	-	Current Ratio	2.80	EPS Y/Y TTM	-104.94%	Oper. Margin	-17.31%	RSI (14)	49.38	Volatility	0.93% 1.78%
Employees	140	Debt/Eq	-	Sales Y/Y TTM	28.24%	Profit Margin	-55.03%	Recom	3.00	Target Price	15.00
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	-1126.24%	Payout	-	Rel Volume	1.58	Prev Close	13.83
Sales Surprise	-13.98%	EPS Surprise	-1411.40%	Sales Q/Q	33.73%	Earnings	May 08 BMO	Avg Volume	176.69K	Price	13.81
SMA20	-0.09%	SMA50	-1.92%	SMA200	61.36%	Trades		Volume	276,023	Change	-0.14%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-24-21	Initiated	SVB Leerink	Outperform	$20

May-08-25 07:00AM	LENSAR Reports First Quarter 2025 Results and Provides Business Update (GlobeNewswire)
Apr-24-25 09:20AM	LENSAR: It Is All About The Contingent Value Right Now (Seeking Alpha)
Apr-10-25 01:59PM	Alcon: A Clear Vision, But Fully Valued (Seeking Alpha)
08:35AM	Is LENSAR (LNSR) a Deeply Undervalued Stock? (Insider Monkey)
Mar-25-25 09:00AM	Morning Movers: 23andMe plummets after Chapter 11 proceedings and CEO exit (TipRanks)
08:35AM	Loading…
08:35AM	ALC Stock Rises Following the Merger Agreement With LENSAR (Zacks)
Mar-24-25 08:00AM	Alcon Agrees to Acquire LENSAR, Inc. (GlobeNewswire)
Mar-03-25 07:03PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Feb-28-25 02:17AM	LENSAR Inc (LNSR) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... (GuruFocus.com) +19.60%
Feb-27-25 07:00AM	LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update (GlobeNewswire) +14.78%
Feb-26-25 08:18AM	Earnings To Watch: LENSAR Inc (LNSR) Reports Q4 2024 Result (GuruFocus.com)
Feb-19-25 12:00PM	LENSAR to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 27, 2025 (GlobeNewswire)
Feb-03-25 07:33PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.63%
Jan-02-25 06:08PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Dec-09-24 04:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
08:00AM	Loading…
Nov-26-24 08:00AM	LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day (GlobeNewswire)
Nov-08-24 02:14AM	LENSAR Inc (LNSR) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion (GuruFocus.com) +7.42%
Nov-07-24 07:00AM	LENSAR Reports Third Quarter 2024 Results and Provides Business Update (GlobeNewswire) +17.24%
Nov-06-24 07:53AM	LENSAR Inc (LNSR) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Nov-01-24 06:32PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.28% +8.92%
Oct-31-24 07:00AM	LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024 (GlobeNewswire)
Oct-09-24 08:15AM	Lensar announces more than 1M procedures completed with cataract laser systems (TipRanks)
Oct-08-24 08:00AM	One Millionth Procedure Completed Using LENSAR's Cataract Laser Systems (GlobeNewswire) +6.11%
Oct-01-24 06:25PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-04-24 04:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
08:00AM	LENSAR to Participate in Two Upcoming Investor Conferences (Business Wire)
Aug-08-24 07:00AM	LENSAR Reports Second Quarter 2024 Results and Provides Business Update (Business Wire) -9.93%
Aug-07-24 07:00AM	LENSAR Announces Certification for the ALLY Adaptive Cataract Treatment System in the European Union (Business Wire) -7.90%
Aug-01-24 06:42PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
07:00AM	LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 (Business Wire)
10:00AM	Loading…
Jul-05-24 10:00AM	3 Under-$10 Stocks With the Potential to Make You a Millionaire (InvestorPlace)
Jul-02-24 05:50PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +5.80%
Jun-03-24 06:34PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -7.33%
May-23-24 08:00AM	LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference (Business Wire)
May-13-24 11:14AM	LENSAR, Inc. (NASDAQ:LNSR) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 11:57AM	LNSR Stock Earnings: LENSAR Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +12.68%
07:00AM	LENSAR Reports First Quarter 2024 Results and Provides Business Update (Business Wire)
May-02-24 08:00AM	LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 (Business Wire)
May-01-24 06:38PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-01-24 06:28PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-05-24 09:11AM	LENSAR, Inc. (NASDAQ:LNSR) Q4 2023 Earnings Call Transcript (Insider Monkey) -10.97%
Mar-04-24 07:00AM	LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update (Business Wire)
Mar-01-24 05:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-26-24 08:00AM	LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024 (Business Wire)
Nov-12-23 09:38AM	LENSAR, Inc. (NASDAQ:LNSR) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 07:00AM	LENSAR Reports Third Quarter 2023 Results and Provides Business Update (Business Wire) +12.44%
Nov-02-23 08:03AM	LENSAR to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023 (Business Wire) +5.12%
Aug-09-23 07:00AM	LENSAR Reports Second Quarter 2023 Results and Provides Business Update (Business Wire) +12.73%
Jul-24-23 07:00AM	LENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology Groups (Business Wire)
May-15-23 07:00AM	LENSAR Reports First Quarter 2023 Results and Provides Business Update (Business Wire) -9.45%
May-10-23 08:00AM	LENSAR to Report First Quarter 2023 Financial Results on Monday, May 15, 2023 (Business Wire)
Mar-20-23 03:05AM	LENSAR, Inc. (NASDAQ:LNSR) Q4 2022 Earnings Call Transcript (Insider Monkey) -10.98%
Mar-16-23 07:00AM	LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update (Business Wire)
Mar-09-23 08:00AM	LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023 (Business Wire)
Feb-14-23 07:00AM	LENSAR Announces Preliminary Fourth Quarter and Full Year 2022 Results (Business Wire)
Nov-22-22 08:00AM	LENSAR to Present at Two Upcoming Investor Conferences (Business Wire)
Nov-09-22 07:00AM	LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update (Business Wire) -11.56%
Nov-02-22 08:00AM	LENSAR to Report Third Quarter 2022 Financial Results on Wednesday, November 9, 2022 (Business Wire)
Sep-08-22 07:00AM	LENSAR Announces Application for Certification of the ALLY Adaptive Cataract Treatment System in the EU (Business Wire)
Aug-16-22 07:00AM	First Patients Treated with LENSARs® ALLY Adaptive Cataract Treatment System (Business Wire)
Aug-08-22 07:00AM	LENSAR Reports Second Quarter 2022 Financial Results and Provides Business Update (Business Wire)
Aug-01-22 08:00AM	LENSAR to Report Second Quarter 2022 Financial Results on Monday, August 8, 2022 (Business Wire)
Jun-13-22 07:00AM	LENSAR® Receives U.S. FDA Clearance of ALLY Adaptive Cataract Treatment System (Business Wire)
Jun-09-22 07:30AM	Shareholders in LENSAR (NASDAQ:LNSR) are in the red if they invested a year ago (Simply Wall St.)
May-09-22 07:00AM	LENSAR Reports First Quarter 2022 Financial Results and Provides Business Update (Business Wire)
May-02-22 08:00AM	LENSAR to Report First Quarter 2022 Financial Results on Monday, May 9, 2022 (Business Wire)
Apr-21-22 09:08AM	We're Not Very Worried About LENSAR's (NASDAQ:LNSR) Cash Burn Rate (Simply Wall St.)
Mar-03-22 07:00AM	LENSAR Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update (Business Wire) +6.34%
Mar-01-22 07:00AM	LENSAR Announces U.S. Food and Drug Administration Acceptance of 510(k) Submission for ALLY (Business Wire)
Feb-28-22 04:01PM	LENSAR to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 3, 2022 (Business Wire)
Feb-23-22 02:01AM	Should Now Consider Selling Your LENSAR (LNSR) Shares? (Insider Monkey)
Feb-10-22 08:00AM	LENSAR to Participate in Two Upcoming Investor Conferences (Business Wire)
Jan-04-22 08:00AM	LENSAR to Present at the H.C. Wainwright Virtual BioConnect Conference (Business Wire)
Dec-31-21 07:53AM	Shareholders in LENSAR (NASDAQ:LNSR) are in the red if they invested a year ago (Simply Wall St.)
Nov-16-21 08:00AM	LENSAR to Present at Two Upcoming Investor Conferences (Business Wire)
Nov-12-21 07:00AM	LENSAR Announces Poster Presentations at the American Academy of Ophthalmology (Business Wire)
Nov-08-21 07:00AM	LENSAR Reports Third Quarter 2021 Financial Results and Provides Business Update (Business Wire)
Nov-01-21 08:00AM	LENSAR to Report Third Quarter 2021 Financial Results on Monday, November 8, 2021 (Business Wire)
Oct-02-21 10:32AM	We Think LENSAR (NASDAQ:LNSR) Can Afford To Drive Business Growth (Simply Wall St.)
Sep-02-21 08:00AM	LENSAR to Present at the H.C. Wainwright 23rd Annual Global Investment Conference (Business Wire)
Aug-16-21 08:00AM	LENSAR to Present at the H.C. Wainwright Ophthalmology Virtual Conference (Business Wire)
Aug-05-21 07:00AM	LENSAR Reports Second Quarter 2021 Financial Results and Provides Business Update (Business Wire)
Jul-29-21 08:00AM	LENSAR to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021 (Business Wire)
Jul-15-21 08:00AM	LENSAR Announces In-Person Demonstrations of Its Next Generation ALLY System and Multiple Data Presentations at the American Society of Cataract and Refractive Surgery (ASCRS) 2021 Annual Meeting (Business Wire)
May-24-21 08:00AM	LENSAR to Present at the Oppenheimer MedTech, Tools, & Diagnostics Summit (Business Wire)
May-05-21 07:00AM	LENSAR Reports First Quarter 2021 Financial Results and Provides Business Update (Business Wire)
06:45AM	LENSAR Inc to Host Earnings Call (ACCESSWIRE)
Apr-28-21 08:00AM	LENSAR to Hold First Quarter 2021 Financial Results Conference Call on Wednesday, May 5, 2021 (Business Wire)
Mar-10-21 07:00AM	LENSAR Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update (Business Wire) +5.58%
Mar-03-21 04:05PM	LENSAR to Hold Fourth Quarter and Full Year 2020 Financial Results and Business Update Conference Call on Wednesday, March 10, 2021 (Business Wire) -6.13%
Feb-16-21 01:28PM	Is LENSAR Inc. (LNSR) A Smart Long-Term Buy? (Insider Monkey)
Feb-08-21 08:00AM	LENSAR to Present at Two Upcoming Investor Conferences (Business Wire) +8.67%
Feb-01-21 07:00AM	LENSAR Expands Board of Directors with the Appointments of Aimee S. Weisner and Elizabeth G. OFarrell (Business Wire)
Jan-03-21 03:58AM	We Think LENSAR (NASDAQ:LNSR) Needs To Drive Business Growth Carefully (Simply Wall St.)
Nov-23-20 08:00AM	LENSAR to Present at the 32nd Annual Piper Sandler Virtual Healthcare Conference (Business Wire)
Nov-11-20 04:01PM	LENSAR Announces Presentations at American Academy of Ophthalmology Highlighting the Advantages of Streamline IV in Both Cataract and Astigmatism Corrective Surgery (Business Wire) -6.84%
Nov-09-20 04:01PM	LENSAR Reports Third Quarter 2020 Financial Results and Provides Business Update (Business Wire) +7.54% +8.60%
Nov-02-20 08:00AM	LENSAR to Hold Third Quarter 2020 Financial Results and Business Update Conference Call on Monday, November 9, 2020 (Business Wire)

LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Winer Gary M	Director	Sep 03 '24	Buy	4.50	685	3,082	80,840	Sep 06 09:00 AM
Winer Gary M	Director	Aug 28 '24	Buy	4.45	1,000	4,450	80,155	Aug 29 06:05 AM
Winer Gary M	Director	Aug 26 '24	Buy	4.58	802	3,673	78,655	Aug 29 06:05 AM
Winer Gary M	Director	Aug 27 '24	Buy	4.50	500	2,250	79,155	Aug 29 06:05 AM
Winer Gary M	Director	Aug 21 '24	Buy	4.35	500	2,176	77,851	Aug 23 06:52 PM
Winer Gary M	Director	Aug 22 '24	Buy	4.30	2	9	77,853	Aug 23 06:52 PM
Winer Gary M	Director	Aug 20 '24	Buy	4.20	500	2,100	77,351	Aug 20 05:24 PM
Winer Gary M	Director	Aug 16 '24	Buy	4.03	6	24	76,851	Aug 20 05:24 PM
Winer Gary M	Director	Aug 14 '24	Buy	4.20	1,000	4,200	76,845	Aug 14 08:31 PM
Winer Gary M	Director	Aug 12 '24	Buy	4.03	500	2,015	75,845	Aug 14 08:31 PM
STAAB THOMAS R II	Chief Financial Officer	Aug 08 '24	Option Exercise	2.65	3,500	9,275	162,434	Aug 12 04:30 PM

HCWB

HCW Biologics Inc

LNSR

LENSAR Inc

Upgrade your FINVIZ experience